comparemela.com

Latest Breaking News On - Esophagogastric junction - Page 1 : comparemela.com

A Review of Anti-HER2 Targeted Agents in Non-Breast Solid Tumors

This review summarizes current utilization of anti-HER2 targeted therapy across several non-breast solid tumors in the setting of advanced disease.

South koreaUniversity of washingtonUnited statesMegan alhadeffJavlem overexpressionThanh buiTiffany tamChemother pharmacolKanwal pratap singh raghavSalvatore sienaVan cutsemAtsuo takashimaDaiichi sankyoFred hutchinson cancer centerAmerican society for clinical pathologyAmerican society of clinical oncology

Implantica announces that RefluxStop™ results were presented at the DDW Conference in Chicago

/PRNewswire/ Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that Dr. med. Zehetner, Prof..

United statesPeter forsellNicole pehrssonJuanita eberhartAmerican foregut society white paperCorporate affairsKlinik beau siteDigestive disease weekHirslanden klinik beau site bernIneffective esophageal motilityChief corporate affairsNasdaq first north premier growth marketCertified adviserLower esophageal sphincterEndoscopic classificationEsophagogastric junction

Implantica announces that RefluxStop results were presented at the DDW Conference in Chicago

VADUZ, Liechtenstein, May 16, 2023 /PRNewswire/ Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that Dr. med. Zehetner, Prof.

United statesJuanita eberhartNicole pehrssonPeter forsellAmerican foregut society white paperCorporate affairsKlinik beau siteDigestive disease weekHirslanden klinik beau site bernIneffective esophageal motilityChief corporate affairsNasdaq first north premier growth marketCertified adviserLower esophageal sphincterEndoscopic classificationEsophagogastric junction

Implantica announces Dr med Yves Borbély Presented his 3-year Data on RefluxStop™ at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)

/PRNewswire/ Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that Dr. Borbély from.

United statesJuanita eberhartPeter forsellNicole pehrssonYves borbCorporate affairsUniversity clinic for visceral surgeryAmerican foregut societyUniversity hospitalAmerican foregut society white paperVisceral surgeryUniversity clinicMedicine inselspitalEmerging technologyAddress gastroesophageal refluxNasdaq first north premier growth market

SOTIO Initiates CLAUDIO-01 Trial with Antibody-Drug Conjugate SOT102 in Patients with Gastric and Pa

CLAUDIO-01 is the first-in-human trial of SOT102, a 2 (Claudin 18.2) targeting antibody-drug conjugate (ADC) The trial will enroll up to 109 patients with gastric and pancreatic cancerPRAGUE, Czech Republic, April 26, 2022 / B3C newswire / SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group.

Czech republicUnited statesRadka obermannovaJosep taberneroMichael tattoryRadek spisekRichard kapsaLifesci communicationsHebron university hospitalMasaryk memorial cancer instituteDrug developmentMedical oncologyClinical trialsPancreatic neoplasmsEsophagogastric junctionStomach neoplasms

vimarsana © 2020. All Rights Reserved.